2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the …

NI Parikh, JM Gonzalez, CAM Anderson, SE Judd… - Circulation, 2021 - Am Heart Assoc
This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as
hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for …

Pregnancy and reproductive risk factors for cardiovascular disease in women

AC O'Kelly, ED Michos, CL Shufelt, JV Vermunt… - Circulation …, 2022 - Am Heart Assoc
Beyond conventional risk factors for cardiovascular disease, women face an additional
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …

[HTML][HTML] The Swedish medical birth register during five decades: documentation of the content and quality of the register

S Cnattingius, K Källén, A Sandström… - European journal of …, 2023 - Springer
Pregnancy-related factors are important for short-and long-term health in mothers and
offspring. The nationwide population-based Swedish Medical Birth Register (MBR) was …

Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications: systematic review and meta-analysis

SM Grandi, KB Filion, S Yoon, HT Ayele, CM Doyle… - Circulation, 2019 - Am Heart Assoc
Background: Women with a history of certain pregnancy complications are at higher risk for
cardiovascular (CVD) disease. However, most clinical guidelines only recommend …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association

C Bushnell, LD McCullough, IA Awad, MV Chireau… - Stroke, 2014 - Am Heart Assoc
Purpose—The aim of this statement is to summarize data on stroke risk factors that are
unique to and more common in women than men and to expand on the data provided in …

Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies

GMB Louis, J Grewal, PS Albert, A Sciscione… - American journal of …, 2015 - Elsevier
Objective Fetal growth is associated with long-term health yet no appropriate standards exist
for the early identification of undergrown or overgrown fetuses. We sought to develop …

[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …

MF Piepoli, AW Hoes, S Agewall, C Albus… - European heart …, 2016 - ncbi.nlm.nih.gov
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Intimate partner violence during pregnancy: maternal and neonatal outcomes

JL Alhusen, E Ray, P Sharps, L Bullock - Journal of women's health, 2015 - liebertpub.com
The effects of intimate partner violence (IPV) on maternal and neonatal outcomes are
multifaceted and largely preventable. During pregnancy, there are many opportunities within …